Strategy
Target for Anti-cancer Drugs
Developing an Early Diagnostic Marker of Cancer
Supplying a Marker for Pathological Diagnosis of Cancer
 

HomeAbout usStrategy

 
Project
 

1. Target for Anti-cancer Drugs

  Molecular Target Drug (anti-cancer drugs) with high efficiency and little side-effect

 


 Rapid progress of molecular biology makes it possible to grasp the characteristics of cancer cells on the molecular level and to develop the "Molecular Target Drug" which can selectively attack the cancer cell and give little damage to normal tissues.

 We have developed our own tools and technologies to reveal abnormal human genes. We are able to comprehensively analyze human genes at a stretch by using our proprietary “Whole Genome DNA Array” that can identify many new genes with high amplifications, with its functions unqualified.

 Our aim is to make the "Molecular Target Drug" with high efficiency and little side-effect that can attack the specific molecules in cancer cells.




Home > Strategy > Target for Anti-cancer Drugs
 
Copyright(c) 2006 LinkGenomics, Inc. All rights reserved.